Alignment Healthcare, Inc. SEC Filings

Alignment Healthcare CEO share transactions: Shares associated with Chief Executive Officer and director John E. Kao, held indirectly through the JEK Trust for which he serves as trustee, were sold in two transactions on 01/12/2026 under a Rule 10b5-1 trading plan adopted on 03/12/2025. The trust sold 177,273 shares of common stock at a weighted-average price of $21.0997 per share and an additional 2,727 shares at a weighted-average price of $21.5665 per share, with individual trades occurring within the disclosed price ranges.

Following these sales, indirect holdings reported as held by the JEK Trust totaled 2,832,641 shares, and direct holdings reported in John Kao’s name totaled 1,568,379 shares of Alignment Healthcare common stock.

Alignment Healthcare, Inc. used a current report to update its growth outlook and reaffirm guidance. The company estimates about 275,300 health plan members as of January 1, 2026, which it states is roughly 31% growth versus January 1, 2025. It also expects 290,000 to 296,000 members by December 31, 2026, or about 24% to 27% growth relative to the midpoint of its latest 2025 year-end membership guidance.

The company also says current consensus for 2026 adjusted EBITDA of approximately $145 million will fall within its planned full-year 2026 guidance range, which it intends to provide with its fourth-quarter 2025 earnings. For 2025, it reaffirms prior guidance, including health plan membership of 232,500 to 234,500, revenue of $3,931 million to $3,946 million, adjusted gross profit of $474 million to $483 million, and adjusted EBITDA of $90 million to $98 million.

ALHC submitted a Form 144 notice covering a planned sale of 318,152 shares of common stock, with an aggregate market value of $6,681,192.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, where the stock is listed, with an approximate sale date of 01/06/2026. The filing notes that 200,091,742 shares of common stock were outstanding.

The seller acquired 228,152 common shares on 12/31/2025 via performance stock units and 90,000 common shares on 09/30/2019 through restricted and performance stock units, both from the issuer. Over the past three months, sales disclosed include 100,000 shares on 01/02/2026 for $2,003,450.00, and additional transactions in December 2025, some labeled as 10b5-1 sales for Dawn Maroney. The signatory represents they are not aware of undisclosed material adverse information about the issuer.

Alignment Healthcare president Dawn C. Maroney reported open-market sales of company common stock executed under a Rule 10b5-1 trading plan adopted on 05/22/2025. On December 12, 2025, she sold 16,681 shares at a weighted-average price of $20.0204 per share, leaving 1,780,556 shares directly owned. On December 15, 2025, she sold 113,319 shares at a weighted-average price of $20.0068 per share, and directly held 1,667,237 shares afterward. For each date, the weighted-average prices reflect multiple trades within narrow price ranges disclosed in the report.

General Atlantic (ALN HLTH), L.P., a 10% owner of Alignment Healthcare, Inc., reported an open market sale of 11,119,494 shares of common stock at $18.57 per share, settled on December 12, 2025.

After this transaction, it beneficially owned 13,476,585 shares of Alignment Healthcare common stock indirectly, with the structure involving multiple General Atlantic investment funds and shares and restricted stock units held by Nicholas Robbert Vorhoff and David C. Hodgson for the benefit of General Atlantic Service Company, L.P.

A group of reporting persons led by General Atlantic (ALN HLTH), L.P., which is identified as a director and 10% owner of Alignment Healthcare, Inc., reported a large open-market sale of the company’s common stock. On December 12, 2025, they sold 11,119,494 shares of common stock at a net price of $18.57 per share.

After this transaction, the group reports indirect beneficial ownership of 13,476,585 Alignment Healthcare shares. This includes 13,167,733 shares held directly by General Atlantic (ALN HLTH), L.P., plus additional shares and 18,710 restricted stock units for each of Nicholas Robbert Vorhoff and David C. Hodgson held for the benefit of General Atlantic Service Company, L.P. The reporting persons describe a multi-entity General Atlantic structure and state that each disclaims beneficial ownership beyond any pecuniary interest.

Alignment Healthcare, Inc. reported an insider transaction by Sebastian Burzacchi, its chief operating officer for the management services organization. On 12/10/2025, he sold 12,585 shares of Alignment Healthcare common stock at $19.26 per share. According to the explanation, this represents the number of shares required to be sold to cover tax withholding obligations in connection with the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. After the sale, he beneficially owns 237,793 shares of Alignment Healthcare common stock held directly.

Alignment Healthcare, Inc. disclosed that Chief Executive Officer and director John E. Kao sold 180,000 shares of common stock on 12/10/2025. The sale was reported at a weighted-average price of $19.0179 per share, with individual trades executed between $18.84 and $19.46 under a Rule 10b5-1 trading plan adopted on 03/12/2025.

Following this transaction, Kao beneficially owns 2,346,726 shares indirectly through the JEK Trust, for which he serves as trustee, and 2,839,942 shares directly.

Alignment Healthcare (ALHC) reported an insider transaction by Director Joseph S. Konowiecki. On 11/11/2025, 4,832 shares of common stock were sold at $16.49. The filing states the sale was to satisfy tax withholding from the vesting of restricted stock units and was not a discretionary trade by the reporting person.

Following the transaction, the director beneficially owns 1,081,141 shares, held directly.